JP7548823B2 - 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ - Google Patents

多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ Download PDF

Info

Publication number
JP7548823B2
JP7548823B2 JP2020567573A JP2020567573A JP7548823B2 JP 7548823 B2 JP7548823 B2 JP 7548823B2 JP 2020567573 A JP2020567573 A JP 2020567573A JP 2020567573 A JP2020567573 A JP 2020567573A JP 7548823 B2 JP7548823 B2 JP 7548823B2
Authority
JP
Japan
Prior art keywords
proadm
level
sample
trauma
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020567573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525879A (ja
JP2021525879A5 (https=
JPWO2019234165A5 (https=
Inventor
ダライアス ウィルソン
アリーン ペラ
シュテファン エーブマイヤー
フラウケ ドレイヤー
Original Assignee
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2021525879A publication Critical patent/JP2021525879A/ja
Publication of JP2021525879A5 publication Critical patent/JP2021525879A5/ja
Publication of JPWO2019234165A5 publication Critical patent/JPWO2019234165A5/ja
Priority to JP2024058795A priority Critical patent/JP2024091650A/ja
Application granted granted Critical
Publication of JP7548823B2 publication Critical patent/JP7548823B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2020567573A 2018-06-06 2019-06-06 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ Active JP7548823B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024058795A JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18176268.3A EP3578989A1 (en) 2018-06-06 2018-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients
EP18176268.3 2018-06-06
PCT/EP2019/064805 WO2019234165A1 (en) 2018-06-06 2019-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024058795A Division JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Publications (4)

Publication Number Publication Date
JP2021525879A JP2021525879A (ja) 2021-09-27
JP2021525879A5 JP2021525879A5 (https=) 2022-06-15
JPWO2019234165A5 JPWO2019234165A5 (https=) 2022-06-15
JP7548823B2 true JP7548823B2 (ja) 2024-09-10

Family

ID=62562975

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020567573A Active JP7548823B2 (ja) 2018-06-06 2019-06-06 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ
JP2024058795A Pending JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024058795A Pending JP2024091650A (ja) 2018-06-06 2024-04-01 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ

Country Status (5)

Country Link
US (1) US12560620B2 (https=)
EP (2) EP3578989A1 (https=)
JP (2) JP7548823B2 (https=)
CN (1) CN112236678B (https=)
WO (1) WO2019234165A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102544219B1 (ko) * 2021-08-17 2023-06-14 한림대학교 산학협력단 코펩틴의 농도를 이용한 외상성 뇌 손상의 진단 방법
EP4658247A1 (en) * 2023-01-31 2025-12-10 Vivacelle Bio, Inc. Compositions and methods for treating hyperprocalcitonemia
CN117964711B (zh) * 2024-04-01 2024-06-11 中国科学院生物物理研究所 非天然抗菌肽及其应用
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017089474A1 (en) 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE69602756T2 (de) 1995-08-18 2000-02-10 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
KR100425525B1 (ko) 2000-11-21 2004-03-30 재단법인서울대학교산학협력재단 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
US8298774B2 (en) * 2007-03-12 2012-10-30 Biomedica Medizinprodukte Gmbh & Co Kg Diagnosis of septic complications
PL2185937T5 (pl) * 2007-09-07 2014-12-31 Univ Zuerich Sposób wykrywania posocznicy u ludzi
ES2486268T3 (es) 2007-11-16 2014-08-18 Biocartis Nv Biomarcadores y procedimientos de diagnóstico, predicción y/o pronóstico de septicemia y usos de los mismos
US9229013B2 (en) 2009-05-05 2016-01-05 B.R.A.H.M.S Gmbh Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
US8383332B2 (en) 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
WO2012059477A1 (en) 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
EP2976646B1 (en) * 2013-03-20 2020-08-19 sphingotec GmbH Adrenomedullin to guide therapy of blood pressure decline
EP4231018A3 (en) 2016-07-08 2023-11-15 SphingoTec GmbH Adrenomedullin for assessing congestion in a subject with acute heart failure
RU2764766C2 (ru) * 2016-08-09 2022-01-21 Б.Р.А.Х.М.С. Гмбх Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
CA3033094A1 (en) * 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017089474A1 (en) 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT

Also Published As

Publication number Publication date
CN112236678B (zh) 2024-10-11
EP3803417A1 (en) 2021-04-14
WO2019234165A1 (en) 2019-12-12
US20210405070A1 (en) 2021-12-30
CN112236678A (zh) 2021-01-15
JP2021525879A (ja) 2021-09-27
EP3578989A1 (en) 2019-12-11
US12560620B2 (en) 2026-02-24
JP2024091650A (ja) 2024-07-05

Similar Documents

Publication Publication Date Title
JP2024091650A (ja) 多発外傷患者の外傷関連合併症の予後診断のためのｐｒｏ－ａｄｍ
JP7344208B2 (ja) ｐｒｏ－ＡＤＭに基づく抗生物質療法の指導
JP7579353B2 (ja) 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン
JP2024023615A (ja) 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ
US20240393352A1 (en) Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
JP7544879B2 (ja) 重篤患者用の療法モニタリングマーカーとしてのｐｒｏ－ａｄｍ
JP7258860B2 (ja) 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ
US20260056215A1 (en) Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma
RU2820944C2 (ru) Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания
RU2782305C2 (ru) Про-адм в качестве маркера мониторинга терапии для критически больных пациентов
RU2788885C2 (ru) Прокальцитонин и про-адм в качестве маркеров для мониторинга лечения антибиотиками

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220606

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220606

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230522

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230822

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240401

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240520

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240815

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240829

R150 Certificate of patent or registration of utility model

Ref document number: 7548823

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150